elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q42377651-941ADFA1-DAF9-4F92-891F-5D30DF6FF5F9
Q42377651-941ADFA1-DAF9-4F92-891F-5D30DF6FF5F9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42377651-941ADFA1-DAF9-4F92-891F-5D30DF6FF5F9
Alemtuzumab in refractory Sézary syndrome.
P433
Q42377651-941ADFA1-DAF9-4F92-891F-5D30DF6FF5F9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42377651-941ADFA1-DAF9-4F92-891F-5D30DF6FF5F9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
34de14692766ef81b95ffb25a01c556e2d2d4cb4
P433
5
http://www.w3.org/2001/XMLSchema#string